Citigroup’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.62K Sell
5,147
-31,262
-86% -$29.2K ﹤0.01% 5331
2025
Q4
$56.4K Buy
36,409
+1,210
+3% +$1.93K ﹤0.01% 4526
2025
Q3
$55.6K Sell
35,199
-32,791
-48% -$57K ﹤0.01% 4456
2025
Q2
$151K Sell
67,990
-10,831
-14% -$26.2K ﹤0.01% 4197
2025
Q1
$213K Sell
78,821
-54,714
-41% -$216K ﹤0.01% 4163
2024
Q4
$542K Buy
133,535
+4,883
+4% +$18.5K ﹤0.01% 3763
2024
Q3
$506K Buy
128,652
+48,913
+61% +$206K ﹤0.01% 3718
2024
Q2
$325K Buy
79,739
+7,894
+11% +$34K ﹤0.01% 3645
2024
Q1
$311K Buy
71,845
+1,617
+2% +$7.59K ﹤0.01% 3823
2023
Q4
$316K Buy
70,228
+11,170
+19% +$43.5K ﹤0.01% 3694
2023
Q3
$184K Sell
59,058
-29,864
-34% -$120K ﹤0.01% 3692
2023
Q2
$396K Buy
88,922
+27,832
+46% +$128K ﹤0.01% 3532
2023
Q1
$295K Sell
61,090
-268,166
-81% -$1.32M ﹤0.01% 3505
2022
Q4
$1.73M Sell
329,256
-509,486
-61% -$3.12M ﹤0.01% 2154
2022
Q3
$5.43M Sell
838,742
-527,085
-39% -$2.94M ﹤0.01% 1508
2022
Q2
$6.3M Buy
1,365,827
+1,307,680
+2,249% +$6.44M ﹤0.01% 1396
2022
Q1
$412K Sell
58,147
-21,078
-27% -$144K ﹤0.01% 3639
2021
Q4
$795K Buy
79,225
+27,374
+53% +$294K ﹤0.01% 3468
2021
Q3
$629K Buy
+51,851
New +$782K ﹤0.01% 3458

Other funds holding MXCT

Citigroup's MXCT Position: Q1 2026 in Review

Citigroup reduced its MaxCyte (MXCT) stake by 86% in Q1 2026, selling an estimated $29.2K and leaving 5,147 shares worth $3.62K. The position accounts for ﹤0.01% of the portfolio, ranked #5331.

Citigroup first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $6.3M in Q2 2022. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Citigroup held 5,147 shares of MaxCyte worth $3.62K as of Q1 2026.
  • Citigroup sold 31,262 MaxCyte shares in Q1 2026, an estimated $29.2K.
  • MaxCyte made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5331 holding.
  • Citigroup first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • Citigroup's MaxCyte position peaked at $6.3M in Q2 2022.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.